ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

On November 2, 2009, the Registrant completed the sale of its CBI Services and Fairfax Identity Laboratories divisions (collectively, the "Divisions") to Bostwick Laboratories, Inc. a Delaware corporation (the "Purchaser"), pursuant to the terms of an Asset Purchase Agreement dated July 16, 2009, which was filed as Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on July 22, 2009. Prior to the sale of the Divisions, the Registrant and its affiliates did not have any relationship of a material nature with the Purchaser. The material terms of the transaction are described in the Registrant's Current Report on Form 8-K filed on July 22, 2009.

---

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

COMMONWEALTH BIOTECHNOLOGIES, INC.

By: /S/ RICHARD J. FREER, PH.D. Richard J. Freer, Ph.D. Chief Operating Officer

Dated: November 6, 2009